NASDAQ:ALDX

Aldeyra Therapeutics Stock Predictions

etoro logo Buy ALDX
*Your capital is at risk
$1.64
-0.0200 (-1.20%)
At Close: Jun 02, 2026
Currently predicting for Thu, 4 Jun 2026

ALDX Prediction Chart

ALDX Predictions History

Latest community submissions for ALDX.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 20, 2025 $6.77 +2.85% $6.72 V 99.30% 4
Mar 20, 2025 $6.70 +1.78% $6.72 V 99.66% 5
Mar 20, 2025 Bullish $6.72 V 1
Apr 15, 2024 $4.38 +2.96% $4.16 X 94.81% 0
Apr 15, 2024 $4.33 +1.85% $4.16 X 95.95% 0
thedean2010 thedean2010 Merchant
Apr 15, 2024 Bearish $4.16 V 1
Feb 27, 2024 $3.58 -2.06% $3.77 X 95.08% 0
Feb 27, 2024 $3.61 -1.29% $3.77 X 95.83% 0
Feb 27, 2024 Bullish $3.77 V 1
Dec 20, 2023 $3.44 -2.06% $3.36 V 97.69% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALDX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ALDEYRA THERAPEUTICS
Aldeyra Therapeutics
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE